Clinical Trial Update: Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports the completion of a study evaluating personalized treatment strategies based on therapeutic monitoring for metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: Rennes University Hospital | Conditions: Colorectal Cancer Metastatic | Phase 4 | Status: COMPLETED